Abbott, USA: Medical Devices, Diagnostics, Diabetes, Nutrition and Healthcare Products

by pritamkurrey111 · Published December 1, 2025 · Updated September 12, 2026

Introduction

Abbott Laboratories, commonly known as Abbott, is a major American healthcare and medical technology company headquartered in the United States. Founded in 1888, Abbott has developed from a pharmaceutical business into a diversified global healthcare company operating across medical devices, diagnostics, diabetes care, nutrition, biowearables, medicines, cardiovascular technology and pain-and-movement therapies.

Today, Abbott serves customers and patients in more than 160 countries and has more than 120,000 employees worldwide, according to the company’s current corporate information. Its portfolio spans areas including cardiovascular care, diabetes, diagnostics testing, nutrition, medicines, biowearables and pain and movement.

Abbott is therefore different from companies that specialize mainly in one type of medical equipment. Its products range from heart stents and pacemakers to glucose sensors, laboratory diagnostic systems, nutritional products and neuromodulation devices.

What Does Abbott Make?

Abbott develops and markets products in several major healthcare categories:

Cardiovascular medical devices
Heart rhythm management systems
Pacemakers
Leadless pacemakers
Cardiac electrophysiology systems
Cardiac mapping and ablation technologies
Coronary stents
Structural heart devices
Heart failure technologies
Diabetes monitoring systems
Continuous glucose monitoring (CGM)
Laboratory diagnostic instruments
Molecular diagnostic systems
Rapid diagnostic tests
Point-of-care testing systems
Nutrition products
Infant and pediatric nutrition
Adult nutritional supplements
Medical nutrition
Pain-management devices
Deep brain stimulation systems
Spinal cord stimulation systems
Biowearables
Established pharmaceutical products
Eye-care and vision-related technologies

Abbott’s official product portfolio is organized into categories including Biowearables, Cancer, Cardiovascular, Diabetes, Diagnostics Testing, Medicines, Nutrition, and Pain and Movement.

1. Abbott Cardiovascular Devices

Cardiovascular technology is one of Abbott’s most important medical-device businesses.

The company develops devices used to diagnose and treat diseases affecting the heart and blood vessels.

Its cardiovascular portfolio includes technologies for:

Coronary artery disease
Heart rhythm disorders
Structural heart disease
Heart failure
Peripheral vascular disease
Aortic and mitral valve conditions
Electrophysiology procedures

Abbott’s medical-device portfolio includes both implantable devices and minimally invasive technologies.

2. Coronary Stents

Abbott is well known for its coronary stent technologies.

A coronary stent is a small mesh-like device placed inside a narrowed or blocked coronary artery to help maintain blood flow after an intervention.

One of Abbott’s well-known product families is XIENCE, a drug-eluting coronary stent platform.

Drug-eluting stents release medication locally to help reduce the likelihood of tissue growth that could narrow the treated artery again.

Abbott lists vascular devices, including coronary technologies, among its medical-product focus areas.

3. Heart Rhythm Management

Abbott also develops technologies for people with abnormal heart rhythms.

This area includes:

Pacemakers
Leadless pacemakers
Implantable cardiac defibrillators
Cardiac resynchronization systems
Electrophysiology catheters
Cardiac mapping systems
Ablation technologies

These devices can help physicians diagnose and treat different types of cardiac rhythm disorders.

4. Leadless Pacemakers

One of Abbott’s newer cardiovascular technologies is the AVEIR leadless pacemaker system.

Unlike traditional pacemakers that generally use leads connecting the implanted pulse generator to the heart, leadless pacemakers are designed to be implanted directly within the heart.

Abbott’s AVEIR portfolio includes leadless pacing technology, including systems designed for specific pacing applications. The company has also been developing conduction-system pacing technology through its AVEIR platform.

The exact indication and availability of a particular device depend on regulatory approval in each country.

5. Electrophysiology and Cardiac Ablation

Abbott also makes technologies used in cardiac electrophysiology (EP).

Electrophysiology procedures help physicians understand and treat abnormal electrical activity in the heart.

Abbott’s EP technologies include:

Cardiac mapping systems
Mapping catheters
Ablation catheters
Electrophysiology recording systems
Navigation technologies

These technologies can be used during procedures for conditions such as atrial fibrillation and other cardiac arrhythmias.

6. Structural Heart Devices

Structural heart disease involves abnormalities in the physical structures of the heart.

Abbott develops minimally invasive technologies for conditions involving:

Mitral valves
Tricuspid valves
Aortic valves
Congenital heart conditions

The company’s structural-heart portfolio includes transcatheter technologies designed to treat selected patients without conventional open-heart surgery.

Abbott’s Tendyne transcatheter mitral valve replacement system is one example of its structural-heart development. The company reported FDA approval for Tendyne in 2025.

7. Heart Failure Technologies

Abbott also works in the area of heart failure management.

Its technologies include systems designed to help physicians monitor or manage patients with advanced heart failure.

Depending on the therapy, Abbott’s cardiovascular technologies can provide:

Cardiac stimulation
Rhythm management
Hemodynamic monitoring
Implantable therapeutic support
Remote patient information

The aim is to give clinicians additional information and therapeutic options for managing complex cardiac conditions.

8. Diabetes Care

Diabetes management is another major Abbott business.

Abbott is especially well known for its FreeStyle Libre continuous glucose monitoring systems.

Continuous glucose monitoring, or CGM, uses a small sensor to measure glucose levels continuously or at frequent intervals.

Instead of relying exclusively on conventional finger-stick measurements, CGM can provide ongoing glucose information through a sensor and compatible reader or smartphone application.

Abbott identifies FreeStyle Libre as one of its major diabetes products.

9. FreeStyle Libre Continuous Glucose Monitoring

The FreeStyle Libre family is among Abbott’s best-known healthcare technologies.

A typical CGM system includes:

A wearable glucose sensor
A reader or smartphone application
Glucose data
Trend information
Alerts on compatible systems
Digital tools for diabetes management

Different FreeStyle Libre models and indications vary by market.

Abbott’s official product information notes that availability and indications can differ by geography and product version.

10. Biowearables

Abbott has expanded beyond traditional medical equipment into biowearable technologies.

Biowearables use sensors to collect physiological information and combine it with software or smartphone applications.

Abbott’s portfolio includes:

FreeStyle Libre
Lingo
Other sensor-based technologies

The company describes these systems as combining sensors with digital applications to convert physiological information into useful insights.

11. Lingo Biosensor

Lingo is one of Abbott’s newer consumer-oriented biowearable technologies.

The system uses a biosensor and smartphone application to provide information related to glucose levels and lifestyle patterns.

Unlike prescription diabetes-management systems, Lingo is positioned for a different user population and is not intended to diagnose disease.

Abbott’s official information states that Lingo is intended for adults 18 years and older who are not using insulin and is not intended for diagnosis of diseases such as diabetes.

12. Diagnostic Testing

Abbott is also a major developer of diagnostic testing technologies.

Its diagnostic products are used in:

Hospitals
Medical laboratories
Clinics
Blood banks
Point-of-care environments
Home testing

The company’s diagnostic portfolio includes laboratory analyzers, molecular testing systems, rapid tests and point-of-care platforms.

13. Laboratory Diagnostic Systems

Abbott develops large laboratory systems designed to process clinical samples.

Its portfolio includes product families such as:

Alinity
ARCHITECT
CELL-DYN
m2000
RealTime PCR
Other laboratory platforms

These systems can support testing in areas such as:

Clinical chemistry
Immunoassay
Hematology
Molecular diagnostics
Infectious disease testing
Blood screening

Abbott’s official product list includes multiple Alinity and ARCHITECT systems as well as other laboratory platforms.

14. Point-of-Care Testing

Abbott also develops diagnostic equipment that can be used closer to the patient rather than exclusively inside a central laboratory.

Point-of-care technologies can provide clinicians with rapid information during:

Emergency care
Critical care
Clinics
Ambulance and transport environments
Hospitals
Other healthcare settings

The Abbott portfolio includes the i-STAT family of point-of-care testing systems.

15. Rapid Diagnostic Tests

Abbott also produces rapid diagnostic tests.

One well-known example is BinaxNOW, which includes rapid testing products for respiratory infections.

Abbott currently lists BinaxNOW COVID-19 and COVID-19/flu combination tests among its diagnostic offerings in the United States.

The availability and regulatory status of specific rapid tests vary between countries.

16. Molecular Diagnostics

Molecular diagnostics is another important area of Abbott’s testing business.

Molecular diagnostic systems can detect genetic material associated with infectious diseases and other medical conditions.

Abbott’s portfolio includes molecular platforms and technologies such as:

RealTime PCR
m2000 systems
Alinity m
Other molecular testing technologies

These platforms are used by clinical laboratories for different types of molecular testing.

17. Hematology and Blood Testing

Abbott also produces technologies for hematology and blood-related diagnostic testing.

Its portfolio includes hematology analyzers and other laboratory systems.

These technologies can help laboratories evaluate characteristics of blood cells and support the diagnosis or monitoring of various conditions.

Abbott’s product list includes the CELL-DYN family of hematology analyzers.

18. Nutrition Products

Abbott is not only a medical-device manufacturer.

Nutrition is one of its largest global healthcare businesses.

The company develops nutritional products for:

Infants
Children
Adults
Older adults
People with specific medical nutrition requirements
People managing certain chronic conditions

Abbott’s major nutrition brands include:

Similac
Ensure
PediaSure
Glucerna
Pedialyte
Nepro
Jevity
Osmolite
EleCare

Abbott’s official nutrition portfolio includes these and other products.

19. Similac

Similac is one of Abbott’s best-known infant nutrition brands.

It includes infant and child nutrition products designed for different nutritional needs.

Formula availability, composition and regulatory requirements can vary between countries, so consumers should use products according to local labeling and healthcare guidance.

20. PediaSure

PediaSure is a pediatric nutritional product line.

It is designed for children with particular nutritional requirements, depending on the product and market.

The PediaSure portfolio is part of Abbott’s broader pediatric nutrition business.

21. Ensure

Ensure is Abbott’s major adult nutrition brand.

Products in the Ensure family are designed for different nutritional needs and may provide combinations of:

Protein
Calories
Vitamins
Minerals
Other nutrients

Abbott states that Ensure was introduced in 1973 and has developed into a broad portfolio of adult nutritional products.

22. Glucerna

Glucerna is a specialized nutrition brand associated with diabetes management and nutritional needs.

The product range is designed around nutritional considerations for people with diabetes or concerns related to blood glucose management.

Specific formulations and availability differ by country.

23. Medical Nutrition

Abbott also produces specialized medical nutrition products.

These can be used in healthcare environments for patients who require nutrition support.

The portfolio includes products for:

Enteral feeding
Disease-specific nutrition
Specialized medical nutrition
Pediatric nutrition
Kidney-related nutritional needs
Other clinical requirements

Abbott identifies medical nutrition as one of its important nutrition-product areas.

24. Pain and Movement Technologies

Abbott has a specialized medical-device business focused on pain and movement.

This includes technologies for conditions such as:

Chronic pain
Parkinson’s disease
Essential tremor
Other neurological movement disorders

The company’s current portfolio includes spinal cord stimulation and deep brain stimulation systems.

25. Spinal Cord Stimulation

Spinal cord stimulation (SCS) is a technology used in selected patients with chronic pain.

Abbott’s portfolio includes:

Proclaim systems
Eterna rechargeable SCS
Other neuromodulation technologies

These systems use electrical stimulation to alter pain signaling.

The appropriate device and treatment approach depend on the patient’s condition and specialist assessment.

26. Deep Brain Stimulation

Abbott also develops Deep Brain Stimulation (DBS) technologies.

DBS involves delivering electrical stimulation to specific areas of the brain through implanted electrodes.

Abbott’s product portfolio includes the Infinity DBS System and related technologies.

DBS may be considered for certain neurological movement disorders under specialist care.

27. NeuroSphere Digital Health

Abbott’s neuromodulation portfolio also includes digital technologies.

NeuroSphere Digital Health is designed to support connected care around Abbott’s neuromodulation therapies.

Connected technologies can help clinicians manage information related to implanted therapy and patient care.

28. Abbott’s Pharmaceutical Business

Although Abbott is strongly associated with medical devices and diagnostics, it also has a pharmaceutical business.

The company currently describes its medicines portfolio as established pharmaceuticals, with products available particularly in emerging markets. Areas include:

Women’s health
Cardiometabolic conditions
Gastroenterology
Oncology
Immunology
Neurology and other therapeutic areas

Abbott’s current U.S. product information notes that its medicines portfolio is available in emerging markets.

29. Abbott Medicines in India

Abbott has a particularly large pharmaceutical presence in India.

According to Abbott’s India corporate fact sheet, the company has a portfolio of more than 400 brands in India across areas including women’s health, neuropsychiatry, liver care, metabolic disorders, pain, gastroenterology, cardiovascular conditions and anti-infective therapies.

Some well-known Abbott brands in India include:

Thyronorm
Digene
Duphaston
Vertin
Duphalac
Udiliv
Stemetil

These medicines are used for different medical conditions and should be taken according to appropriate medical advice and product labeling.

30. Abbott Vision Care

Abbott also has a presence in eye care and ophthalmic technology.

Its vision-related products include technologies used in areas such as:

Cataract surgery
Refractive correction
Corneal care
Intraocular lenses

Abbott’s India information has identified vision care as one of its medical-product businesses and lists TECNIS intraocular lens technologies among its products.

Abbott’s Major Healthcare Businesses

Abbott can broadly be understood through several major business areas: Business Area Main Products and Technologies Cardiovascular Stents, pacemakers, structural heart devices, EP systems Diabetes FreeStyle Libre CGM Biowearables FreeStyle Libre, Lingo Diagnostics Laboratory analyzers, molecular testing, rapid tests Pain & Movement SCS, DBS, neuromodulation Nutrition Similac, Ensure, PediaSure, Glucerna, Nepro Medicines Established pharmaceutical brands Vision Care Intraocular lenses and ophthalmic technologies Point-of-Care i-STAT and other rapid diagnostic platforms

Abbott’s official portfolio confirms these broad categories and individual product families.

Abbott’s Global Presence

Abbott is a global healthcare company with operations and products serving more than 160 countries.

Its technologies are used across hospitals, laboratories, clinics, pharmacies, homes and other healthcare environments. The company currently reports more than 120,000 employees worldwide and says its products and technologies serve more than 2 billion people globally.

Abbott in India

India is an important market for Abbott.

The company’s Indian operations cover multiple healthcare areas, including:

Pharmaceuticals
Nutrition
Medical products
Diagnostics
Diabetes care
Vision care

Abbott’s India corporate fact sheet specifically identifies vascular products, diagnostic instruments, diabetes-care technologies and vision-care products within its medical-products business.

The company’s Indian pharmaceutical portfolio is particularly extensive, with more than 400 brands reported in its India fact sheet.

Abbott’s Role in Modern Healthcare

One of Abbott’s biggest strengths is the combination of diagnosis, monitoring, treatment and nutrition under one company.

For example, Abbott can participate in different stages of a patient’s healthcare journey:

Diagnostic Testing → Disease Monitoring → Medical Treatment → Long-Term Management → Nutrition and Recovery Support

This broad portfolio allows Abbott to serve both healthcare professionals and consumers.

Frequently Asked Questions

1. What is Abbott?

Abbott is a U.S.-based global healthcare company founded in 1888. It develops medical devices, diagnostic technologies, diabetes-monitoring systems, nutritional products, medicines and other healthcare technologies.

2. What medical devices does Abbott make?

Abbott makes cardiovascular devices, coronary stents, pacemakers, leadless pacemakers, electrophysiology systems, structural-heart technologies, neuromodulation devices and other medical technologies.

3. What is Abbott FreeStyle Libre?

FreeStyle Libre is Abbott’s continuous glucose monitoring technology. It uses a wearable sensor and compatible digital technology to provide glucose information.

4. Does Abbott make heart stents?

Yes. Abbott develops coronary drug-eluting stents, including the XIENCE family.

5. Does Abbott make pacemakers?

Yes. Abbott develops conventional cardiac rhythm-management technologies as well as leadless pacemaker systems such as AVEIR.

6. What diagnostic machines does Abbott make?

Abbott makes laboratory and point-of-care diagnostic systems, including Alinity, ARCHITECT, CELL-DYN, i-STAT, molecular diagnostic platforms and other testing systems.

7. What nutrition brands does Abbott own?

Major Abbott nutrition brands include Similac, Ensure, PediaSure, Glucerna, Pedialyte, Nepro, Jevity and other specialized nutrition products.

8. Does Abbott operate in India?

Yes. Abbott has extensive operations in India across pharmaceuticals, nutrition, diagnostics, diabetes care, vascular products and vision care.

9. Is Abbott only a medical-device company?

No. Abbott is a diversified healthcare company. Its businesses include medical devices, diagnostics, diabetes technology, nutrition, biowearables, medicines and pain-and-movement technologies.

Conclusion

Abbott, USA is one of the world’s major diversified healthcare technology companies. Its products cover a remarkably wide range of healthcare needs, from coronary stents and pacemakers to glucose sensors, laboratory diagnostic systems, nutritional products and neurological stimulation devices.

Its cardiovascular business makes technologies for heart rhythm, structural heart disease and vascular conditions, while its diabetes business is globally recognized for the FreeStyle Libre continuous glucose monitoring platform. Abbott’s diagnostics business provides laboratory, molecular and point-of-care testing systems, and its nutrition division serves infants, children, adults and patients with specialized nutritional requirements.

With operations spanning more than 160 countries and a portfolio that combines medical devices, diagnostics, nutrition, digital health and medicines, Abbott has become an important part of the modern global healthcare industry.